Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid-Free Shoulder Arthroplasty
NCT03540030Phase 4Completed
- Sponsor
- OrthoCarolina Research Institute
- Start
- Sep 2016
- Primary completion
- Mar 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label trial of gabapentin, celecoxib, ketorolac, acetaminophen and bupivacaine in postoperative pain (2 arms), sponsored by OrthoCarolina Research Institute. Primary endpoint: Post Operative Pain at 24 hours. Started Sep 2016; status: completed.
02
Drugs
gabapentincelecoxibketorolacacetaminophenbupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03540030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03540030.